Holen Sie sich die Stockscreener-App
30.78
0.06%
-0.02
Finanzdaten der Edgewise Therapeutics Inc-Aktie (EWTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
2.63%
34.75
|
33.86 | 29.45 | 25.34 | 25.70 |
| Operating Income/Loss |
2.63%
-34.75
|
-33.86 | -29.45 | -25.34 | -25.70 |
| Income/Loss From Continuing Operations Before Tax |
5.37%
-28.52
|
-30.14 | -25.71 | -21.47 | -22.84 |
| Income/Loss From Continuing Operations After Tax |
5.37%
-28.52
|
-30.14 | -25.71 | -21.47 | -22.84 |
|
Net Income/Loss
|
5.37%
-28.52
|
-30.14 | -25.71 | -21.47 | -22.84 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
24,620%
87.57
|
0.3542 | 63.46 | 63.38 | 63.27 |
| Diluted Average Shares |
24,620%
87.57
|
0.3542 | 63.46 | 63.38 | 63.27 |
| Basic Earnings Per Share |
29.79%
-0.33
|
-0.47 | -0.41 | -0.34 | -0.36 |
| Diluted Earnings Per Share |
29.79%
-0.33
|
-0.47 | -0.41 | -0.34 | -0.36 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):